TITLE

HCV co-infection in HIV positive population in British Columbia, Canada

AUTHOR(S)
Buxton, Jane A.; Yu, Amanda; Kim, Paul H.; Spinelli, John J.; Kuo, Margot; Alvarez, Maria; Gilbert, Mark; Krajden, Mel
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10 Issue 1, p225
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: As HIV and hepatitis C (HCV) share some modes of transmission co-infection is not uncommon. This study used a population-based sample of HIV and HCV tested individuals to determine the prevalence of HIV/HCV coinfection, the sequence of virus diagnoses, and demographic and associated risk factors. Methods: Positive cases of HIV were linked to the combined laboratory database (of negative and positive HCV antibody results) and HCV reported cases in British Columbia (BC). Results: Of 4,598 HIV cases with personal identifiers, 3,219 (70%) were linked to the combined HCV database, 1,700 (53%) of these were anti-HCV positive. HCV was diagnosed first in 52% of co-infected cases (median time to HIV identification 3 ½ years). HIV and HCV was diagnosed within a two week window in 26% of cases. Among individuals who were diagnosed with HIV infection at baseline, subsequent diagnoses of HCV infection was independently associated with: i) intravenous drug use (IDU) in males and females, Hazard Ratio (HR) = 6.64 (95% CI: 4.86-9.07) and 9.76 (95% CI: 5.76-16.54) respectively; ii) reported Aboriginal ethnicity in females HR = 2.09 (95% CI: 1.34-3.27) and iii) males not identified as men-who-have-sex-with-men (MSM), HR = 2.99 (95% CI: 2.09-4.27). Identification of HCV first compared to HIV first was independently associated with IDU in males and females OR = 2.83 (95% CI: 1.84-4.37) and 2.25 (95% CI: 1.15-4.39) respectively, but not Aboriginal ethnicity or MSM. HIV was identified first in 22%, with median time to HCV identification of 15 months; Conclusion: The ability to link BC public health and laboratory HIV and HCV information provided a unique opportunity to explore demographic and risk factors associated with HIV/HCV co-infection. Over half of persons with HIV infection who were tested for HCV were anti-HCV positive; half of these had HCV diagnosed first with HIV identification a median 3.5 years later. This highlights the importance of public health follow-up and harm reduction measures for people identified with HCV to prevent subsequent HIV infection.
ACCESSION #
51137610

 

Related Articles

  • Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Mohsen, A.H.; Easterbrook, P.J.; Taylor, C.; Portmann, B.; Kulasegaram, R.; Murad, S.; Wiselka, M.; Norris, S. // Gut;Jul2003, Vol. 52 Issue 7, p1035 

    Objectives: To compare the rate of hepatic fibrosis progression in hepatitis C virus (HCV) infected and human immunodeficiency virus (HIV)-HCV coinfected patients, and to identify factors that may influence fibrosis progression. Patients and methods: A total of 153 HCV infected and 55 HCV-HIV...

  • Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus. Martinez-Sierra, Carmen; Arizcorreta, Ana; Díaz, Fernando; Roldán, Rafael; Martín-Herrera, Leopoldo; Pérez-Guzmán, Eugenio; Girón-González, José A. // Clinical Infectious Diseases;2/15/2003, Vol. 36 Issue 4, p491 

    To evaluate the factors associated with the evolution of chronic hepatitis C in human immunodeficiency virus (HIV)-infected patients, a cross-sectional analysis of 41 HIV-infected patients with chronic hepatitis C (known as "HIV-HCV [hepatitis C virus]-coinfected patients") and a control group...

  • Deaths from hepatitis C overtake deaths from HIV in the US.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/3/2012, Vol. 344 Issue 7846, p12 

    The article reports that there are more individuals who died from hepatitis C (15, 106) in the U.S. in 2007 than those who died from HIV (12, 734) based on the analysis of U.S. death certificates.

  • Evolution of Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus in Patients Treated with Highly Active Antiretroviral Therapy. Torre, D.; Tambini, R.; Cadario, F.; Barbarini, G.; Moroni, M.; Basilico, C. // Clinical Infectious Diseases;11/1/2001, Vol. 33 Issue 9, p1579 

    Focuses on a study which examined patients coinfected with HIV and hepatitis C virus (HCV) who were treated with highly active antiretroviral therapy in Italy. Characteristics of the study population; Survival rate of patients coinfected with HIV and HCV; Evolution of HCV genotypes and disease.

  • Prevalence and Characteristics of Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus Clinical Trials Group: The Terry Beirn Community Programs for Clinical Research on AIDS. Tedaldi, Ellen M.; Hullsiek, Katherine Hoppler; Malvestutto, Carlos D.; Arduino, Roberto C.; Fisher, Evelyn J.; Gaglio, Paul J.; Jenny-Avital, Elizabeth R.; McGowan, Joseph P.; Perez, George // Clinical Infectious Diseases;5/15/2003, Vol. 36 Issue 10, p1313 

    The baseline prevalence of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection among 2705 patients enrolled in HIV clinical trials in the Community Programs for Clinical Research on AIDS (CPCRA) was 16.6%. For men, multivariate logistic regression showed that the baseline...

  • Canada's Prisons: High Risk.  // Guide;Jun2003, Vol. 23 Issue 6, p112 

    Reports on an increase in HIV and hepatitis C infection rates in federal prisons in Canada. Voluntary tests for inmates; Likely causes of the infections.

  • HIV/HCV Koenfeksiyonu: Olgu Sunumu. KUMBASAR KARAOSMANOĞLU, Hayat; ALTUNTAŞ AYDIN, Özlem; RAHŞAN İNCE, Emine; NAZLICAN, Özcan // Viral Hepatitis Journal / Viral Hepatit Dergisi;Aug2013, Vol. 19 Issue 2, p89 

    HIV/HCV coinfection is common due to shared routes of transmission. Co-infection affects disease progression related to both agents and complicates treatment. In this report, a 48-year old male patient with HIV/HCV coinfection has been presented.

  • Table of Contents.  // Clinical Infectious Diseases;Dec2014, Vol. 59 Issue 12, pNP 

    A table of the contents for December 15, 2014 issue is presented.

  • Transmission of HCV NS5A Inhibitor–Resistant Variants Among HIV-Infected Men Who Have Sex With Men. Abravanel, Florence; Métivier, Sophie; Chauveau, Marie; Péron, Jean-Marie; Izopet, Jacques // Clinical Infectious Diseases;11/1/2016, Vol. 63 Issue 9, p1271 

    A letter to the editor is presented in response to the article about hepatitis C virus drug resistance associated HIV infection in men in the previous issue.

  • Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human... Sulkowski, Mark S.; Mast, Eric E.; Seeff, Leonard B.; Thomas, David L. // Clinical Infectious Diseases;4/1/2000 Supplement 1, Vol. 30, pS77 

    Discusses ways in which hepatitis C virus (HCV) infection acts as an opportunistic disease (OI) in HIV-positive persons. How the incidence of infection is increased and the natural history of HCV infection is accelerated in coinfected persons; Strategies designed to prevent HCV infection;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics